Chao Zhang

Prof. Dr. Chao Zhang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
LHLian-Jun He
Lian-Jun He
YZYi-Bao Zhu
Yi-Bao Zhu
QFQing-Zhu Fan
Qing-Zhu Fan
DMDong-Dong Miao
Dong-Dong Miao
SZSheng-Peng Zhang
Sheng-Peng Zhang
CZChao Zhang
Chao Zhang

29 October 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JZJi Zhou
Ji Zhou
LYLi-Zhen Yu
Li-Zhen Yu
YFYa-Li Fan
Ya-Li Fan
CGCi-Hao Guo
Ci-Hao Guo
XLXiao-Mei Lv
Xiao-Mei Lv
CZChao Zhang
Chao Zhang

1 December 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
QFQing-Zhu Fan
Qing-Zhu Fan
JZJi Zhou
Ji Zhou
YZYi-Bao Zhu
Yi-Bao Zhu
LHLian-Jun He
Lian-Jun He
DMDong-Dong Miao
Dong-Dong Miao
CZChao Zhang
Chao Zhang

1 September 2022 in Academic Radiology
Verified
Journal Article
Closed access
XWXin Wang
Xin Wang
CZChao Zhang
Chao Zhang
FCFeng Cao
Feng Cao
CWChuan-Bin Wang
Chuan-Bin Wang
JDJiangning Dong
Jiangning Dong
ZWZhen-Huan Wang
Zhen-Huan Wang

3 June 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
SZSheng-Peng Zhang
Sheng-Peng Zhang
JZJi Zhou
Ji Zhou
QFQing-Zhu Fan
Qing-Zhu Fan
XLXiao-Mei Lv
Xiao-Mei Lv
TWTian Wang
Tian Wang
YZYe-Ming Zhang
Ye-Ming Zhang
Colorectal cancer (CRC) is one of the most common cancer types and a leading cause of cancer‑associated mortality in China. Increased thioredoxin reductase 1 (TrxR1) levels have been previously identified as possible target for CRC. The present study revealed that the natural product hydroxytyrosol (HT), which exhibits a polyphenol scaffold, is a potent inhibitor of TrxR1. Inhibition of TrxR1 was indicated to result in accumulation of reactive oxygen species, inhibit proliferation and induce apoptosis and G1/S cell cycle arrest of CRC cells. Using a C‑terminal mutant TrxR1 enzyme activity assay, TrxR1 RNA interference assay and HT binding model assay, the present study demonstrated the core character of the selenocysteine residue in the interaction between HT and TrxR1. HT can serve as polyphenol scaffold to develop novel TrxR1 inhibitors for CRC treatment in the future.

5 March 2025 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JZJi Zhou
Ji Zhou
QSQing-Ju Shu
Qing-Ju Shu
TWTian Wang
Tian Wang
HHHui-Dan Huang
Hui-Dan Huang
SZSheng-Peng Zhang
Sheng-Peng Zhang
CZChao Zhang
Chao Zhang